ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 243 filers reported holding ICU MED INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $234,769 | +17.3% | 1,977 | +6.0% | 0.00% | 0.0% |
| Q1 2024 | $200,152 | -42.0% | 1,865 | -35.7% | 0.00% | -60.0% |
| Q3 2023 | $345,367 | -21.3% | 2,902 | +17.8% | 0.01% | -16.7% |
| Q2 2023 | $438,882 | -12.2% | 2,463 | -18.7% | 0.01% | -14.3% |
| Q1 2023 | $499,829 | +5.2% | 3,030 | +0.4% | 0.01% | -12.5% |
| Q4 2022 | $475,275 | +16.5% | 3,018 | +11.3% | 0.01% | 0.0% |
| Q3 2022 | $408,000 | -9.7% | 2,712 | -1.4% | 0.01% | -11.1% |
| Q2 2022 | $452,000 | -7.0% | 2,751 | +25.9% | 0.01% | +12.5% |
| Q1 2022 | $486,000 | -7.6% | 2,185 | -1.4% | 0.01% | 0.0% |
| Q4 2021 | $526,000 | +1.2% | 2,216 | -0.5% | 0.01% | -20.0% |
| Q3 2021 | $520,000 | +9.9% | 2,227 | -3.0% | 0.01% | +11.1% |
| Q2 2021 | $473,000 | -12.2% | 2,296 | -12.5% | 0.01% | -18.2% |
| Q1 2021 | $539,000 | -2.4% | 2,623 | +2.0% | 0.01% | -8.3% |
| Q4 2020 | $552,000 | +14.8% | 2,572 | -2.3% | 0.01% | 0.0% |
| Q3 2020 | $481,000 | +14.5% | 2,633 | +15.5% | 0.01% | +9.1% |
| Q2 2020 | $420,000 | – | 2,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |